Charles Schwab’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Charles Schwab’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-14,029	Closed	-$558K	–	3102
2016 Q3	$558K	Hold	14,029	–	–	﹤0.01%	2576
2016 Q2	$177K	Buy	+14,029	New	+$131K	﹤0.01%	2981
2014 Q4	–	Sell	-6,722	Closed	-$69K	–	3117
2014 Q3	$69K	Buy	6,722 +4,200	+167%	+$83K	﹤0.01%	3051
2014 Q2	$155K	Buy	+2,522	New	+$153K	﹤0.01%	3036

Charles Schwab's TBRA Position: Q4 2016 in Review

Charles Schwab sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 14,029 shares — an estimated $558K sold.

Charles Schwab first reported a position in TBRA in Q2 2014 and held it in 4 quarters. The position peaked at $558K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Charles Schwab reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Charles Schwab sold 14,029 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $558K.
Charles Schwab first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 4 quarters.
Charles Schwab's Tobira Therapeutics, Inc. Common Stock position peaked at $558K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Charles Schwab's 13F filing for Q4 2016, filed 13 Feb 2017.